424 related articles for article (PubMed ID: 33834845)
1. Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice.
Mullen L; Meah MN; Elamin A; Aggarwal S; Shahzad A; Shaw M; Hasara J; Rashid M; Fisher M; Ali T; Patel B; Ding WY; Grainger R; Heseltine T; Kirmani BH; Obeidat M; Kasolo Y; Thatchil J; Khand A
J Am Heart Assoc; 2021 Apr; 10(8):e019467. PubMed ID: 33834845
[TBL] [Abstract][Full Text] [Related]
2. Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial.
Park DW; Kwon O; Jang JS; Yun SC; Park H; Kang DY; Ahn JM; Lee PH; Lee SW; Park SW; Choi SW; Lee SG; Yoon HJ; Ahn T; Kim MH; Nah DY; Lee SY; Chae JK; Park SJ;
Circulation; 2019 Dec; 140(23):1865-1877. PubMed ID: 31553203
[TBL] [Abstract][Full Text] [Related]
3. Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies.
Harris J; Pouwels KB; Johnson T; Sterne J; Pithara C; Mahadevan K; Reeves B; Benedetto U; Loke Y; Lasserson D; Doble B; Hopewell-Kelly N; Redwood S; Wordsworth S; Mumford A; Rogers C; Pufulete M
Health Technol Assess; 2023 May; 27(8):1-257. PubMed ID: 37435838
[TBL] [Abstract][Full Text] [Related]
4. Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries.
Bianco M; Careggio A; Biolè CA; Quadri G; Quiros A; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solè A; Liebetrau C; Manzano-Fernàndez S; Boccuzzi G; Henriques JPS; Spirito A; Templin C; Wilton SB; Velicki L; Correia L; Rognoni A; Ugo F; Nunez-Gil I; Fujii T; Durante A; Song X; Kawaji T; Alexopoulos D; Huczek Z; Gonzàlez Juanatey JR; Nie SP; Kawashiri MA; Morbiducci U; Dominguez-Rodriguez A; Destefanis P; Luciano A; De Ferrari GM; Varbella F; Montagna L; D'Ascenzo F; Cerrato E
Cardiovasc Drugs Ther; 2021 Dec; 35(6):1171-1182. PubMed ID: 34224052
[TBL] [Abstract][Full Text] [Related]
5. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
[TBL] [Abstract][Full Text] [Related]
6. In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Project.
Zhao G; Zhou M; Ma C; Huo Y; Smith SC; Fonarow GC; Ge J; Han Y; Liu J; Hao Y; Liu J; Wang X; Taubert KA; Morgan L; Zhao D; Nie S;
J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29602767
[TBL] [Abstract][Full Text] [Related]
7. Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial.
Ueland T; Åkerblom A; Ghukasyan T; Michelsen AE; Aukrust P; Becker RC; Bertilsson M; Himmelmann A; James SK; Siegbahn A; Storey RF; Kontny F; Wallentin L;
J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29330256
[TBL] [Abstract][Full Text] [Related]
8. Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk.
Baber U; Leisman DE; Cohen DJ; Gibson CM; Henry TD; Dangas G; Moliterno D; Kini A; Krucoff M; Colombo A; Chieffo A; Sartori S; Witzenbichler B; Steg PG; Pocock SJ; Mehran R
Circ Cardiovasc Qual Outcomes; 2019 Jan; 12(1):e004945. PubMed ID: 30606052
[TBL] [Abstract][Full Text] [Related]
9. Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database.
Blin P; Dureau-Pournin C; Benichou J; Bonello L; Dallongeville J; Danchin N; Falissard B; Thomas-Delecourt F; Jové J; Lassalle R; Droz C; Moore N
Atherosclerosis; 2019 Feb; 281():98-106. PubMed ID: 30658197
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes after ticagrelor and clopidogrel in Chinese post-stented patients.
Sun Y; Li C; Zhang L; Yu T; Ye H; Yu B; Tao M; Jiang J; Yan J; Wang Y; Zeng H; Shen X; Wang DW
Atherosclerosis; 2019 Nov; 290():52-58. PubMed ID: 31568962
[TBL] [Abstract][Full Text] [Related]
11. Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.
Gimbel M; Qaderdan K; Willemsen L; Hermanides R; Bergmeijer T; de Vrey E; Heestermans T; Tjon Joe Gin M; Waalewijn R; Hofma S; den Hartog F; Jukema W; von Birgelen C; Voskuil M; Kelder J; Deneer V; Ten Berg J
Lancet; 2020 Apr; 395(10233):1374-1381. PubMed ID: 32334703
[TBL] [Abstract][Full Text] [Related]
12. Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry.
Gragnano F; Moscarella E; Calabrò P; Cesaro A; Pafundi PC; Ielasi A; Patti G; Cavallari I; Antonucci E; Cirillo P; Pignatelli P; Palareti G; Pelliccia F; Gaudio C; Sasso FC; Pengo V; Gresele P; Marcucci R;
Intern Emerg Med; 2021 Mar; 16(2):379-387. PubMed ID: 32557093
[TBL] [Abstract][Full Text] [Related]
13. Prognosis and the Effect of De-Escalation of Antiplatelet Therapy After Nuisance Bleeding in Patients With Myocardial Infarction.
Choo EH; Choi IJ; Lim S; Moon D; Kim CJ; Park MW; Kim MC; Hwang BH; Lee KY; Seok Choi Y; Kim HY; Yoo KD; Jeon DS; Ahn Y; Chang K;
Circ Cardiovasc Interv; 2022 Dec; 15(12):e012157. PubMed ID: 36382599
[TBL] [Abstract][Full Text] [Related]
14. Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Turgeon RD; Koshman SL; Youngson E; Har B; Wilton SB; James MT; Graham MM
JAMA Intern Med; 2020 Mar; 180(3):420-428. PubMed ID: 31930361
[TBL] [Abstract][Full Text] [Related]
15. High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT.
Zocca P; Kok MM; van der Heijden LC; van Houwelingen KG; Hartmann M; de Man FHAF; Stoel MG; Louwerenburg JHW; Knottnerus IL; Linssen GCM; Doggen CJM; von Birgelen C
Int J Cardiol; 2018 Oct; 268():11-17. PubMed ID: 29801763
[TBL] [Abstract][Full Text] [Related]
16. Contemporary Use of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A GRACE Risk Score Stratification-Based Analysis in a Large-Scale, Real-World Study From China.
Qiu M; Na K; Qi Z; Zhou H; Li P; Xu K; Wang B; Liu H; Li J; Li Y; Han Y
Mayo Clin Proc; 2023 Jul; 98(7):1021-1032. PubMed ID: 37419570
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Ticagrelor versus Clopidogrel in East Asian Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Treated with Dual Antiplatelet Therapy: A Meta-Analysis of Randomized Controlled Trials.
Li J; Wang Q; Wu C; Qu X; Zhang L; He X; Ma S; Qiu M; Wang X
Cardiology; 2023; 148(4):363-373. PubMed ID: 37094558
[TBL] [Abstract][Full Text] [Related]
18. Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
Åkerblom A; Wojdyla DM; Wallentin L; James SK; de Souza Brito F; Steg PG; Cannon CP; Katus HA; Himmelmann A; Storey RF; Becker RC; Lopes RD;
Am Heart J; 2019 Jul; 213():57-65. PubMed ID: 31108273
[TBL] [Abstract][Full Text] [Related]
19. Age- and Sex-Specific Disparities in Outcomes After Ticagrelor Versus Clopidogrel in East Asian Patients.
Jang MH; Kim AR; Kim T; Oh HJ; Lee JH; Lee YJ; Kim S; Lee J; Kim JH; Cha SJ; Kim TO; Kang DY; Lee PH; Ahn JM; Park DW; Park SJ;
Am J Cardiol; 2023 Nov; 207():237-244. PubMed ID: 37757520
[TBL] [Abstract][Full Text] [Related]
20. Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
Andell P; James SK; Cannon CP; Cyr DD; Himmelmann A; Husted S; Keltai M; Koul S; Santoso A; Steg PG; Storey RF; Wallentin L; Erlinge D;
J Am Heart Assoc; 2015 Oct; 4(10):e002490. PubMed ID: 26452988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
